EP3609495
NK1-ANTAGONIST COMBINATION AND METHOD FOR TREATING SYNUCLEINOPATHIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.4.2018EP published:
24.7.2024EP application number:
18785191.0
EPO information:
European Patent Register
Max expiry date:
8.4.2038
Title in English:
NK1-ANTAGONIST COMBINATION AND METHOD FOR TREATING SYNUCLEINOPATHIESLanguage of the patent:
English
Timeline
Today
9.4.2018EP application
24.7.2024EP Publication
Owner
Name:
Chase Therapeutics CorporationAddress:
1825 K Street N.W. Suite 520, Washington, DC 20006, US
Inventor
Name:
CHASE, Thomas N.Address:
Washington, District of Columbia 20006, US
Name:
CLARENCE-SMITH, Kathleen E.Address:
Washington, District of Columbia 20006, US
Priority
Number:
201762483555 PDate:
10.4.2017Country:
US
Classification
Categories:
A61K 31/675, A61K 31/5377, A61K 31/428, A61P 25/00, A61P 25/16, A61P 25/28